dsip 15mg Delta Sleep-Inducing Peptide (15mg) DSIP 5mg (Delta Sleep-Inducing Peptide)

Typically administered once daily via subcutaneous injection

Its local pharmacological characteristics provide a new idea for the treatment of obesity.AOD 9604, as an anti-obesity polypeptide targeting subcutaneous adipose tissue, achieves the effect of local fat reduction by activating lipolysis and inhibiting fat production

Do not administer this drug to the following patients: 1) Patients with hypersensitivity to the components of this drug 2) Patients with hypercalcemia, hypercalciuria 3) Patients with calcium oxalate stones 4) Patients with renal impair 5) Patients who are immobilized in a hospital bed 6) Sarcoidosis 7) Patients with pseudoparathyroidism 3

Existen principalmente 4 dimetros diferentes que son: TS140 Dimetro de 14 cm

For general peptide storage guidance, see our Peptide Storage Guide

Neurochemical Research .Read source (2022)